Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroko Shibata

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Biological & Pharmaceutical Bulletin|August 2, 2006
Creation of novel Protein Transduction Domain (PTD) mutants by a phage display-based high-throughput screening systemYohei Mukai, Toshiki Sugita, Tomoko Yamato, et al.
Journal of Pharmaceutical Sciences|February 2, 2022
Subvisible Particles Derived by Dropping Stress Enhance Anti-PEG Antibody Production and Clearance of PEGylated Proteins in MiceTakaki Nakajima, Kazuya Nagano, Yuka Fukuda, et al.
Biological & Pharmaceutical Bulletin|July 3, 2009
Arsenic trioxide inhibits human t cell-lymphotropic virus-1-induced syncytiums by down-regulating gp46Hiromi Nabeshi, Tomoaki Yoshikawa, Haruhiko Kamada, et al.
Cytokine|January 5, 2010
Generation of mouse macrophages expressing membrane-bound TNF variants with selectivity for TNFR1 or TNFR2Hiroko Shibata, Yasuhiro Abe, Yasuo Yoshioka, et al.
Biochemical and Biophysical Research Communications|June 9, 2006
A novel method for construction of gene fragment library to searching epitopesMaki Kawamura, Hiroko Shibata, Haruhiko Kamada, et al.
Journal of Immunological Methods|April 18, 2008
Simple and highly sensitive assay system for TNFR2-mediated soluble- and transmembrane-TNF activityYasuhiro Abe, Tomoaki Yoshikawa, Haruhiko Kamada, et al.
Journal of Molecular Biology|December 17, 2008
Structure-function relationship of tumor necrosis factor (TNF) and its receptor interaction based on 3D structural analysis of a fully active TNFR1-selective TNF mutantYohei Mukai, Hiroko Shibata, Teruya Nakamura, et al.
Biochemical and Biophysical Research Communications|February 27, 2004
Optimal site-specific PEGylation of mutant TNF-alpha improves its antitumor potencyYasuo Yoshioka, Yasuo Tsutsumi, Shinji Ikemizu, et al.
Biochimica Et Biophysica Acta|June 15, 2007
Role of amino acid residue 90 in bioactivity and receptor binding capacity of tumor necrosis factor mutantsHiroko Shibata, Haruhiko Kamada, Kyoko Kobayashi-Nishibata, et al.
Biological & Pharmaceutical Bulletin|March 3, 2004
Selective enhancer of tumor vascular permeability for optimization of cancer chemotherapyYasuo Yoshioka, Yasuo Tsutsumi, Haruhiko Kamada, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Biological & Pharmaceutical Bulletin|August 2, 2006
Creation of novel Protein Transduction Domain (PTD) mutants by a phage display-based high-throughput screening systemYohei Mukai, Toshiki Sugita, Tomoko Yamato, et al.
Journal of Pharmaceutical Sciences|February 2, 2022
Subvisible Particles Derived by Dropping Stress Enhance Anti-PEG Antibody Production and Clearance of PEGylated Proteins in MiceTakaki Nakajima, Kazuya Nagano, Yuka Fukuda, et al.
Biological & Pharmaceutical Bulletin|July 3, 2009
Arsenic trioxide inhibits human t cell-lymphotropic virus-1-induced syncytiums by down-regulating gp46Hiromi Nabeshi, Tomoaki Yoshikawa, Haruhiko Kamada, et al.
Cytokine|January 5, 2010
Generation of mouse macrophages expressing membrane-bound TNF variants with selectivity for TNFR1 or TNFR2Hiroko Shibata, Yasuhiro Abe, Yasuo Yoshioka, et al.
Biochemical and Biophysical Research Communications|June 9, 2006
A novel method for construction of gene fragment library to searching epitopesMaki Kawamura, Hiroko Shibata, Haruhiko Kamada, et al.
Journal of Immunological Methods|April 18, 2008
Simple and highly sensitive assay system for TNFR2-mediated soluble- and transmembrane-TNF activityYasuhiro Abe, Tomoaki Yoshikawa, Haruhiko Kamada, et al.
Journal of Molecular Biology|December 17, 2008
Structure-function relationship of tumor necrosis factor (TNF) and its receptor interaction based on 3D structural analysis of a fully active TNFR1-selective TNF mutantYohei Mukai, Hiroko Shibata, Teruya Nakamura, et al.
Biochemical and Biophysical Research Communications|February 27, 2004
Optimal site-specific PEGylation of mutant TNF-alpha improves its antitumor potencyYasuo Yoshioka, Yasuo Tsutsumi, Shinji Ikemizu, et al.
Biochimica Et Biophysica Acta|June 15, 2007
Role of amino acid residue 90 in bioactivity and receptor binding capacity of tumor necrosis factor mutantsHiroko Shibata, Haruhiko Kamada, Kyoko Kobayashi-Nishibata, et al.
Biological & Pharmaceutical Bulletin|March 3, 2004
Selective enhancer of tumor vascular permeability for optimization of cancer chemotherapyYasuo Yoshioka, Yasuo Tsutsumi, Haruhiko Kamada, et al.
Pageof 9